D. Boral Capital Reiterates “Buy” Rating for Kairos Pharma (NYSEAMERICAN:KAPA)
D. Boral Capital reaffirmed their buy rating on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $9.00 price target on the stock. Kairos Pharma Stock Performance Shares of NYSEAMERICAN KAPA opened at $1.37 on Wednesday. Kairos Pharma has a one […]
D. Boral Capital reaffirmed their buy rating on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $9.00 price target on the stock. Kairos Pharma Stock Performance Shares of NYSEAMERICAN KAPA opened at $1.37 on Wednesday. Kairos Pharma has a one […]
